OVERT Betahistine Hydrochloride 8mg Tablet 1's
RXDRUG-DR-XY37169-1pc
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
Betahistine is an analogue of histamine and is claimed to improve the microcirculation of the labyrinth resulting in reduced endolymphatic pressure. It is used to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.
Dosage/Direction for Use
The usual initial dose is 8 mg to 16 mg three times daily taken preferably with meals; maintenance doses are generally in the range of 24 to 48 mg daily.
Administration
Should be taken with food.
Contraindications
Hypersensitivity to Betahistine.
Special Precautions
Betahistine should not be given to patients with phaeochromocytoma. It should be given with care to patients with asthma, peptic ulcer disease or a history of peptic ulcer disease.
Betahistine is considered to be unsafe in patients with porphyria because it has been shown to be porphyrinogenic in in-vitro systems.
Betahistine is considered to be unsafe in patients with porphyria because it has been shown to be porphyrinogenic in in-vitro systems.
Use In Pregnancy & Lactation
Use in Pregnancy: The safe use of Betahistine during pregnancy has not been established, thus, Betahistine may only be used if potential benefit justifies potential risk to fetus.
Adverse Reactions
Gastrointestinal disturbances, headache, skin rashes and pruritus have been reported.
Drug Interactions
Beta-2 agonists: Effects may be decreased by betahistine (due to bronchoconstrictive or other smooth muscles effects). Histamine antagonists: H1 antagonists may decrease response to betahistine. H2 blockers would not be expected to interfere with activity.
Storage
Store at temperatures not exceeding 30°C.
Action
Pharmacology: Pharmacodynamics: Mechanism of Action: Betahistine has a direct stimulating (agonistic) effect on H1 receptors located on blood vessels in the inner ear. Betahistine dilates the blood vessels within the middle ear which can relieve pressure from excess fluid and act on the smooth muscle. This would give rise to local vasodilation and increased permeability, which would help reverse the underlying problem of endolymphatic hydrops (the main pathological feature is an excess of endolymph fluid producing an increase in pressure in the membranous labyrinth).
Pharmacokinetics: Absorption is rapid and complete. It undergoes hepatic metabolism, and its elimination half-life is 3.4 hours via urine as inactive metabolites.
Pharmacokinetics: Absorption is rapid and complete. It undergoes hepatic metabolism, and its elimination half-life is 3.4 hours via urine as inactive metabolites.
MedsGo Class
Features
Brand
Overt
Full Details
Dosage Strength
8 mg
Drug Ingredients
- Betahistine
Drug Packaging
Tablet 1's
Generic Name
Betahistine Hydrochloride
Dosage Form
Tablet
Registration Number
DR-XY37169
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply